Difficulty: Medium
Average Score: 81%
Practice
Monitoring for a patient prescribed iron for iron deficiency anemia includes:
Correct answer
A
Rationale
Monitoring for a patient prescribed iron for iron deficiency anemia includes a reticulocyte count one week after therapy is started because reticulocytes are immature red blood cells, and an increase in their count indicates the bone marrow's response to iron therapy. This helps evaluate the effectiveness of treatment in increasing red blood cell production.
Complete blood count every two weeks throughout therapy (Option B) is not necessary as the primary focus in iron deficiency anemia is on evaluating red blood cell production, which is best reflected by the reticulocyte count.
Checking hemoglobin level at one week of therapy (Option C) may not show significant changes as it takes time for iron therapy to increase hemoglobin levels significantly. Reticulocyte count is a more sensitive marker for early response to therapy.
INR (International Normalized Ratio) monitoring (Option D) is used to monitor the effectiveness of anticoagulant therapy like warfarin, not iron therapy for anemia.
In an educational context, understanding the rationale behind monitoring parameters for iron deficiency anemia treatment is crucial for healthcare professionals to provide optimal care for patients with this condition. By knowing the significance of specific monitoring tests, healthcare providers can track treatment progress effectively and make informed decisions regarding dose adjustments or additional interventions if needed.
Complete blood count every two weeks throughout therapy (Option B) is not necessary as the primary focus in iron deficiency anemia is on evaluating red blood cell production, which is best reflected by the reticulocyte count.
Checking hemoglobin level at one week of therapy (Option C) may not show significant changes as it takes time for iron therapy to increase hemoglobin levels significantly. Reticulocyte count is a more sensitive marker for early response to therapy.
INR (International Normalized Ratio) monitoring (Option D) is used to monitor the effectiveness of anticoagulant therapy like warfarin, not iron therapy for anemia.
In an educational context, understanding the rationale behind monitoring parameters for iron deficiency anemia treatment is crucial for healthcare professionals to provide optimal care for patients with this condition. By knowing the significance of specific monitoring tests, healthcare providers can track treatment progress effectively and make informed decisions regarding dose adjustments or additional interventions if needed.